BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 36015079)

  • 1. Experimental Studies Indicate That ST-2223, the Antagonist of Histamine H3 and Dopamine D2/D3 Receptors, Restores Social Deficits and Neurotransmission Dysregulation in Mouse Model of Autism.
    Eissa N; Venkatachalam K; Jayaprakash P; Yuvaraju P; Falkenstein M; Stark H; Sadek B
    Pharmaceuticals (Basel); 2022 Jul; 15(8):. PubMed ID: 36015079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The histamine H3R and dopamine D2R/D3R antagonist ST-713 ameliorates autism-like behavioral features in BTBR T+tf/J mice by multiple actions.
    Venkatachalam K; Eissa N; Awad MA; Jayaprakash P; Zhong S; Stölting F; Stark H; Sadek B
    Biomed Pharmacother; 2021 Jun; 138():111517. PubMed ID: 33773463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Multi-Targeting Ligand ST-2223 with Histamine H
    Eissa N; Venkatachalam K; Jayaprakash P; Falkenstein M; Dubiel M; Frank A; Reiner-Link D; Stark H; Sadek B
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33669336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous Antagonism at H3R/D2R/D3R Reduces Autism-like Self-Grooming and Aggressive Behaviors by Mitigating MAPK Activation in Mice.
    Eissa N; Awad MA; Thomas SD; Venkatachalam K; Jayaprakash P; Zhong S; Stark H; Sadek B
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous Blockade of Histamine H
    Eissa N; Jayaprakash P; Stark H; Łażewska D; Kieć-Kononowicz K; Sadek B
    Biomolecules; 2020 Aug; 10(9):. PubMed ID: 32872194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Dual-Active Histamine H
    Eissa N; Azimullah S; Jayaprakash P; Jayaraj RL; Reiner D; Ojha SK; Beiram R; Stark H; Łażewska D; Kieć-Kononowicz K; Sadek B
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32503208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P-cresol Alters Brain Dopamine Metabolism and Exacerbates Autism-Like Behaviors in the BTBR Mouse.
    Pascucci T; Colamartino M; Fiori E; Sacco R; Coviello A; Ventura R; Puglisi-Allegra S; Turriziani L; Persico AM
    Brain Sci; 2020 Apr; 10(4):. PubMed ID: 32294927
    [No Abstract]   [Full Text] [Related]  

  • 8. The dual-active histamine H3 receptor antagonist and acetylcholine esterase inhibitor E100 ameliorates stereotyped repetitive behavior and neuroinflammmation in sodium valproate induced autism in mice.
    Eissa N; Azimullah S; Jayaprakash P; Jayaraj RL; Reiner D; Ojha SK; Beiram R; Stark H; Łażewska D; Kieć-Kononowicz K; Sadek B
    Chem Biol Interact; 2019 Oct; 312():108775. PubMed ID: 31369746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histamine H3 receptor antagonism modulates autism-like hyperactivity but not repetitive behaviors in BTBR T+Itpr3tf/J inbred mice.
    Molenhuis RT; Hutten L; Kas MJH
    Pharmacol Biochem Behav; 2022 Jan; 212():173304. PubMed ID: 34856309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curcumin Potentiates α7 Nicotinic Acetylcholine Receptors and Alleviates Autistic-Like Social Deficits and Brain Oxidative Stress Status in Mice.
    Jayaprakash P; Isaev D; Shabbir W; Lorke DE; Sadek B; Oz M
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risperidone and aripiprazole alleviate prenatal valproic acid-induced abnormalities in behaviors and dendritic spine density in mice.
    Hara Y; Ago Y; Taruta A; Hasebe S; Kawase H; Tanabe W; Tsukada S; Nakazawa T; Hashimoto H; Matsuda T; Takuma K
    Psychopharmacology (Berl); 2017 Nov; 234(21):3217-3228. PubMed ID: 28798977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The histamine H3R antagonist DL77 attenuates autistic behaviors in a prenatal valproic acid-induced mouse model of autism.
    Eissa N; Jayaprakash P; Azimullah S; Ojha SK; Al-Houqani M; Jalal FY; Łażewska D; Kieć-Kononowicz K; Sadek B
    Sci Rep; 2018 Aug; 8(1):13077. PubMed ID: 30166610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kami-shoyo-san ameliorates sociability deficits in ovariectomized mice, a putative female model of autism spectrum disorder, via facilitating dopamine D
    Guo Q; Ebihara K; Fujiwara H; Toume K; Awale S; Araki R; Yabe T; Dong E; Matsumoto K
    J Ethnopharmacol; 2019 May; 236():231-239. PubMed ID: 30862522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysfunctional dopaminergic neurotransmission in asocial BTBR mice.
    Squillace M; Dodero L; Federici M; Migliarini S; Errico F; Napolitano F; Krashia P; Di Maio A; Galbusera A; Bifone A; Scattoni ML; Pasqualetti M; Mercuri NB; Usiello A; Gozzi A
    Transl Psychiatry; 2014 Aug; 4(8):e427. PubMed ID: 25136890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathophysiological Studies of Monoaminergic Neurotransmission Systems in Valproic Acid-Induced Model of Autism Spectrum Disorder.
    Kuo HY; Liu FC
    Biomedicines; 2022 Feb; 10(3):. PubMed ID: 35327362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Striatal increase of dopamine receptor 2 density in idiopathic and syndromic mouse models of autism spectrum disorder.
    Chhabra S; Nardi L; Leukel P; Sommer CJ; Schmeisser MJ
    Front Psychiatry; 2023; 14():1110525. PubMed ID: 36970280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the Partial M1 Muscarinic Cholinergic Receptor Agonist CDD-0102A on Stereotyped Motor Behaviors and Reversal Learning in the BTBR Mouse Model of Autism.
    Athnaiel O; Job GA; Ocampo R; Teneqexhi P; Messer WS; Ragozzino ME
    Int J Neuropsychopharmacol; 2022 Jan; 25(1):64-74. PubMed ID: 34791301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The BTBR mouse model of autism spectrum disorders has learning and attentional impairments and alterations in acetylcholine and kynurenic acid in prefrontal cortex.
    McTighe SM; Neal SJ; Lin Q; Hughes ZA; Smith DG
    PLoS One; 2013; 8(4):e62189. PubMed ID: 23638000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hippocampal Transcriptomic and Proteomic Alterations in the BTBR Mouse Model of Autism Spectrum Disorder.
    Daimon CM; Jasien JM; Wood WH; Zhang Y; Becker KG; Silverman JL; Crawley JN; Martin B; Maudsley S
    Front Physiol; 2015; 6():324. PubMed ID: 26635614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current Enlightenment About Etiology and Pharmacological Treatment of Autism Spectrum Disorder.
    Eissa N; Al-Houqani M; Sadeq A; Ojha SK; Sasse A; Sadek B
    Front Neurosci; 2018; 12():304. PubMed ID: 29867317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.